Clinical Trial Endpoints for the Approval of Non-Small Cell Lung Cancer Drugs and Biologics
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 22, 2015
May 7, 2020
8e9a6bba-beb8-4d9a-8054-5bfd214b7427
Related Documents
Integrated Summary of Effectiveness
Guidance DocumentOctober 8, 2015Center for Drug Evaluation and Research
Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics: Guidance for Industry
Guidance DocumentDecember 19, 2018Center for Drug Evaluation and Research
Clinical Trial Imaging Endpoint Process Standards Guidance for Industry
Guidance DocumentApril 27, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox